Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H
First Department of Pathology, Kochi Medical School, Kohasu, Oko-cho, Nankoku City, Kochi, Japan.
Histol Histopathol. 2003 Jul;18(3):935-42. doi: 10.14670/HH-18.935.
Renal oncocytomas account for about 3-7% of all renal tumors. Macroscopically, the cut surface of the tumor is generally mahogany brown or dark red in color. A central scar is occasionally observed. Histologically, tumor cells with finely granular cytoplasm proliferate in an edematous, myxomatous or hyalinized stroma with a nested, tubulocystic, solid or trabecular pattern. Ultrastructurally, tumor cells contain many mitochondria with lamellar cristae. Mitochondrial DNA alterations are consistently observed in renal oncocytomas. In chromosomal analysis, renal oncocytomas comprise a heterogenous group. Combined loss of chromosomes Y and 1, rearrangements affecting band 11q12-13, involvement of 12q12-13, loss of 14q, and the lack of combination of LOH at specific chromosomal sites have been reported. In differential diagnosis, the histological separation from chromophobe RCCs is of great importance. In such a setting, ultrastructural or chromosomal analysis is very useful. However, there are several findings suggesting a close relationship between chromophobe RCC and oncocytoma. First, both tumors share a phenotype of intercalated cells of the collecting duct system and mitochondrial DNA alterations. Second, some cases of coexistent oncocytoma and chromophobe RCC, designated as "renal oncocytosis", have recently been reported. Third, oncocytic variants of chromophobe RCCs that have similar ultrastructural features to those of oncocytomas have been reported. Fourth, the existence of chromophobe adenoma, which is the benign counterpart of chromophobe RCC and shows loss of chromosomes Y and 1, has recently been suggested. Finally, although almost all oncocytomas behave in a benign fashion, some cases of oncocytoma that caused metastasis or resulted in death have also been reported. Therefore, further studies are needed to resolve these problems and also to elucidate the genetic mechanisms responsible for the occurrence of oncocytomas.
肾嗜酸细胞瘤约占所有肾肿瘤的3 - 7%。大体上,肿瘤切面通常呈红褐色或暗红色。偶尔可见中央瘢痕。组织学上,具有细颗粒状细胞质的肿瘤细胞在水肿、黏液瘤样或玻璃样变的间质中呈巢状、小管囊性、实性或小梁状增殖。超微结构上,肿瘤细胞含有许多具有板层嵴的线粒体。肾嗜酸细胞瘤中始终可观察到线粒体DNA改变。在染色体分析中,肾嗜酸细胞瘤是一个异质性群体。已有报道称其存在Y染色体和1号染色体联合缺失、影响11q12 - 13带的重排、12q12 - 13受累、14q缺失以及特定染色体位点不存在杂合性缺失联合情况。在鉴别诊断中,从嫌色性肾细胞癌进行组织学区分非常重要。在这种情况下,超微结构或染色体分析非常有用。然而,有多项发现提示嫌色性肾细胞癌与嗜酸细胞瘤之间存在密切关系。首先,这两种肿瘤都具有集合管系统闰细胞的表型以及线粒体DNA改变。其次,最近有报道称存在嗜酸细胞瘤与嫌色性肾细胞癌共存的病例,称为“肾嗜酸细胞增多症”。第三,已报道有嫌色性肾细胞癌的嗜酸细胞变体,其超微结构特征与嗜酸细胞瘤相似。第四,最近有人提出存在嫌色性腺瘤,它是嫌色性肾细胞癌的良性对应物,表现为Y染色体和1号染色体缺失。最后,尽管几乎所有嗜酸细胞瘤都表现为良性,但也有一些嗜酸细胞瘤发生转移或导致死亡的病例报道。因此,需要进一步研究来解决这些问题,并阐明导致嗜酸细胞瘤发生的遗传机制。